KW-2450

· Kyowa Kirin Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for KW-2450, covering 2024-04-25 to 2024-04-25. Get the full timeline:

Most recent: Clinical Trial Update: Safety Study to Evaluate KW-2450 in Subjects With Advanced Solid Tumor [Phase 1]